Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 29416 AL 29430

Repetitive transcranial magnetic stimulation for cognitive and emotional symptoms in neurodegenerative diseases: a systematic review and dose-response meta-analysis

Zhang Y, Liu S, Xu K, Shen Y, Liu Z, Wang Y, Bai Y, Wang S.

Neurol Sci. 2025 Dec;46(12):6243-6259. doi: 10.1007/s10072-025-08531-x. Epub 2025 Nov 5.

Validation of the Psychosis and Hallucinations Questionnaire in Lewy Body Dementia

Gunawardana CW, Burke PGR, Matar E, Lewis SJG.

J Geriatr Psychiatry Neurol. 2026 Jul;39(4):368-379. doi: 10.1177/08919887251395314. Epub 2025 Nov 7.

Drug enteric metabolism in gut microbiota-brain crosstalk

Maramai S, Taddei M, Castagnetti A, Viciani E, Koufi FD, Neri I, Boschetti E, Evangelisti C, Ratti S, Baldelli L, Calandra-Buonaura G, Cani I, Cortelli P, Sambati L, Scorziello A, Taglialatela M, Pardini M, Corsaro A, Florio T, Giannini G.

Life Sci. 2025 Dec 15;383:124075. doi: 10.1016/j.lfs.2025.124075. Epub 2025 Nov 7.

Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies

Aung KZ, Zin SS, Wu X, Myint ZW, Karanth S, Estus S, Norris CM, Nelson PT, Fardo DW, Abner EL, Katsumata Y.

Neurobiol Dis. 2025 Dec;217:107190. doi: 10.1016/j.nbd.2025.107190. Epub 2025 Nov 13.

CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression

Coughlin DG, Jain L, Khrestian M, Bozoki AC, Galvin JE, Irwin DJ, Lippa CF, Litvan I, Pillai JA, Tousi B, Lopez OL, Berman S, Tsuang DW, Zabetian CP, Fleisher JE, Taylor AS, Leverenz JB, Bekris LM, Galasko D; Dementia With Lewy Bodies Consortium.

Neurology. 2025 Dec 23;105(12):e214346. doi: 10.1212/WNL.0000000000214346. Epub 2025 Nov 17.

Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer's and Parkinson's disease

Siu ACW, Paudel KR, Singh G, Gupta G, Singh SK, Chellappan DK, De Rubis G, Pathak S, Gregory George Oliver B, Dua K, Dhanasekaran M.

Mol Cell Biochem. 2026 Feb;481(2):669-694. doi: 10.1007/s11010-025-05428-3. Epub 2025 Nov 18.

EEG-based stratification in Alzheimer's disease: Cognitive progression, pathological marker associations, and therapeutic interventions

Pei Z, Zhu L, Ren H, Liu Y, Shi X, Lin Y, Wang J, Li P, Wang P, Ji Y, Zhou Y, Tang X, Jiang X, Tong X, Guo Y.

Clin Neurophysiol. 2026 Jan;182:2111440. doi: 10.1016/j.clinph.2025.2111440. Epub 2025 Nov 15.

Advances in neurological therapies: A review of clinical trials in Alzheimer's, Parkinson's, and multiple sclerosis

de Souza PC, Bezerra TPW, de Melo Rêgo MJB, da Rosa MM.

Am J Med. 2026 Mar;139(3):264-275. doi: 10.1016/j.amjmed.2025.11.025. Epub 2025 Nov 27.

Divergence of cortical neurophysiology across different neurodegenerative disorders compared to healthy ageing

Trubshaw M, Kohl O, Gohil C, van Es MWJ, Quinn AJ, Yoganathan K, Edmond E, Proudfoot M, Zokaei N, Raymont V, Pitt J, Thayanandan T, Thompson AG, Talbot K, Hu MT, Perquin MN, Kocagoncu E, Rowe JB, Woolrich MW, Nobre AC, Turner MR.

Prog Neurobiol. 2026 Feb;257:102865. doi: 10.1016/j.pneurobio.2025.102865. Epub 2025 Dec 4.

GLP-1 receptor agonists in Alzheimer's and Parkinson's disease: endocrine pathways, clinical evidence, and future directions

Gandhi A, Parhizgar A.

Front Endocrinol (Lausanne). 2025 Nov 20;16:1708565. doi: 10.3389/fendo.2025.1708565. eCollection 2025.

Digital App for Speech and Health Monitoring Study (DASH): protocol for a prospective longitudinal case-control observational study for developing speech datasets in neurodegenerative disorders and dementia

Tam J, Weaver C, Ihenacho A, Newton J, Virgo B, Barrett S, Neale J, Perry D, Smith A, Chandran S, Watts O, Pal S; DASH Consortium.

BMJ Open. 2025 Dec 5;15(12):e100222. doi: 10.1136/bmjopen-2025-100222.

Multimodal PET/MR Imaging in Early-onset Alzheimer's Disease With Parkinsonism due to a Novel Presenilin-1 (M233I) Mutation

Fang H, Tang A, Tang C, Lan X, Sun X.

Clin Nucl Med. 2026 Mar 1;51(3):252-253. doi: 10.1097/RLU.0000000000006238. Epub 2025 Nov 21.

Microbiota-brain interaction: The role of gut-derived proteins in addressing various neurological disorders including Parkinson's (PD) and Alzheimer's diseases (AD)

Taj T, Kaushik M, Islam A, Das J, Kumar B, Hussain MS, Ramzan M, Ashique S, Tariq M, Sridhar SB, Yasmin S, Panigrahy UP, Malik T, Ansari MY.

Biomed Pharmacother. 2025 Dec;193:118861. doi: 10.1016/j.biopha.2025.118861. Epub 2025 Dec 8.

Sex differences for symptoms prior to dementia onset in people with Lewy body pathology compared to pure Alzheimer's disease pathology

Tsai A, Gunn-Sandell LB, Wyman-Chick KA, Wang Y, Bayram E.

J Alzheimers Dis. 2026 Feb;109(3):1188-1199. doi: 10.1177/13872877251405437. Epub 2025 Dec 12.

Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024

Isaković J, Athanassiadis A, Khubeis M.

J Mol Med (Berl). 2025 Dec 13;104(1):2. doi: 10.1007/s00109-025-02613-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias